HEALTHY-LONGER GmbH (called further HL)

First neuro-metabolic diagnosis and effective intervention.

In psychiatry of ADHD and comorbid conditions, the absence of clinically actionable support tools for diagnostic and treatment decisions limits clinicians to rely on trial-and-error approaches—resulting in delayed response, suboptimal outcomes, and prolonged patient burden. Many patients do not fully respond to first-line therapies. HealthyMentis addresses this gap with a biology-informed clinical decision support tool enabling patient stratification and treatment optimisation (CDS/TxO).
It complements standard assessment by:
• Translating biological signals from dry urine samples into neurometabolic profiles
• Identifying neural pathway dysfunctions
• Stratifying patients biologically
• Defining functional ADHD subtypes
• Linking subtypes to medication and and nutraceutical options

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No news

Milestone

30.06.2023

Pre-clinical validation of methdology

Deal

31.12.2022

Seed financing round closed

Deal

31.12.2022

Clinical study including financing arranged.

Deal

30.09.2022

LOI / MOU with a reputable specialist clinic chain.

No Jobs

Videos

Company video

https://1drv.ms/v/s!BJR0_XElMub3xBjX4-VAtfPl2hyC?e=9jfDSl5eu0u9Mbp4MrD6DA&at=9

Documents

No Awards

HEALTHY-LONGER GmbH (called further HL)

First neuro-metabolic diagnosis and effective intervention.

Headquarter:
7552 Vulpera

Foundation Date:
March 2021

Technology:

  • Biotech

Sectors:

  • Biotech
  • Digital Health
  • Food
  • Neurology